More on WHWK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/8/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Whitehawk Therapeutics (NQ:WHWK)
Delayed: 3.75 +0.18 (5.04%)
Prev. Close $3.57  
Open$3.49 
52 Wk High$ 
52 Wk Low$ 
Day High$3.94 
Day Low$3.49 
P/E N/A  
EPS$ 
Volume304,431 

Friends, Peers and Foes (?): TEM (more...)

Feb 26, 2026 08:01 AM Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Feb 18, 2026 08:00 AM Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 5, 2026 09:30 AM Oppenheimer Starts Whitehawk Therapeutics (WHWK) at Outperform
Jan 8, 2026 08:05 AM Whitehawk receives FDA clearance for cancer drug trial, submits second application
Jan 8, 2026 08:00 AM Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
Dec 22, 2025 12:07 PM Jones Trading Starts Whitehawk Therapeutics (WHWK) at Buy
Dec 1, 2025 08:02 AM Whitehawk Therapeutics names Margaret Dugan as chief medical officer
Dec 1, 2025 08:00 AM Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
Nov 26, 2025 08:00 AM Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov 20, 2025 04:00 AM Jefferies Reiterates Hold Rating on Whitehawk Therapeutics (WHWK)
View All Articles

Entities mentioned with WHWK

View All Entities